People's Hospital of Tongling City
Tongling, China
Location status: Recruiting
NCT Number: NCT06943807
This is a prospective study designed to evaluate the efficacy of a multi-target fecal DNA test for the early detection of gastric cancer. The test combines Helicobacter pylori gene detection with analysis of fecal methylated DNA markers. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo the multi-target fecal DNA test and complete the gastric cancer risk questionnaire.
Interested in participating?
Request Info40 year and older
All sexes
Observational
Tongling, China
Location status: Recruiting
Sample Selection:
The study will be conducted in selected communities within Tongling City, with a total of 10000-15000 residents recruited
Participants Recruitment:
Tests and Follow-up:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
To compare the sensitivity and specificity of the fecal multi-target DNA test and questionnaire screening for gastric cancer.
Time frame: 2 years
To compare the positive and negative predictive values of the fecal multi-target DNA test and the questionnaire screening method
Time frame: 2 years
To calculate and compare the number of participants needed to screen to identify one case of gastric cancer using the fecal DNA test versus the questionnaire.
Time frame: 2 years
To compare the early gastric cancer detection rate achieved by the fecal multi-target DNA testing and the questionnaire.
Time frame: 2 years
To compare the detection rate of the fecal multi-target DNA testing and the questionnaire for precancerous lesions associated with gastric cancer
Time frame: 2 years
To perform a comprehensive analysis of the performance of all methods and develop an optimized, evidence-based strategy for population-based gastric cancer screening.
Contact information is provided by the study sponsor or research team.
Fudan University
Other
A Prospective Study of Gastric Cancer Screening Based on Fecal Multi-Target DNA Analysis Combined With a Risk Questionnaire
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07529808
Adenocarcinoma, Advanced Gastric Cancer
Fairfax, Virginia, United States
View Trial DetailsNCT07675967
Adenocarcinoma Of Esophagus, Bone Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07481357
Digestive System Diseases, Digestive System Neoplasms
Seongnam, Bundang, South Korea
View Trial DetailsNCT07000253
Digestive System Diseases, Digestive System Neoplasms
Amsterdam, Netherlands
View Trial Details